Method and composition for cancer diagnosis and treatment

Details Method and composition for cancer diagnosis and treatment Method and composition for cancer diagnosis and treatment

2008-09-04

2011-12-13

Aeder, Sean (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Reexamination Certificate

active

08076061

ABSTRACT:
Methods and compositions for inhibiting the onset of cancer, and cancer diagnosis and treatment are provided. The treatment method comprises inhibiting the level or function of transcriptional positive factor 4 (PC4). Also provided are methods of screening for cancer inhibition agents based on inhibition of PC4 expression or function.

REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5132405 (1992-07-01), Huston
patent: 5244805 (1993-09-01), Miller
patent: 5476786 (1995-12-01), Huston
patent: 5723750 (1998-03-01), Stubbs
patent: 6278039 (2001-08-01), Johnson
patent: 2005/0272061 (2005-12-01), Petroziello et al.
patent: 2007/0161018 (2007-07-01), Inazawa et al.
patent: WO/92/02529 (1992-02-01), None
patent: WO/00/04989 (2000-02-01), None
patent: WO/00/05377 (2000-02-01), None
patent: WO 01/25437 (2001-04-01), None
patent: WO/01/75177 (2001-10-01), None
patent: WO/03/008578 (2003-01-01), None
Kretzschmar et al (Cell, 1994, 78: 525-534).
Ge et al (PNAS, 1994, 91: 12691-12695).
Guardavaccaro et al (Cell Growth & Differentiation, 1995, 6: 159-169).
Ge and Roeder, (1994), Purification, cloning and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes. Cell 78, 513-523.
Kretzschmar, M. et al., (1994) A novel mediator of class II gene transcription with homology to viral immediate-early transcriptional regulators. Cell 78, 525-534.
Kishore A. H. et al., (2007) p53 regulates its own activator-transcriptional coactivator PC4: a new p53 responsive gene. Biochem. J. BJ20070390.
Banerjee, S. et al. (2004) General transcriptional coactivator PC4 activates p53 function. Mol. Cell Biol. 24, 2052-2062.
Ge, H. et al., (1994) Phosphorylation negatively regulates the function of coactivator PC4. Proc. Natl. Acad. Sci. USA 91, 12691-12695.
Kumar, P.B.R. et al., (2001) p300-mediated acetylation of human transcriptional coactivator PC4 is inhibited by phosphorylation. J. Biol. Chem. 276, 16804-16809.
Pilch, B. et al., (2001) Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res. 61, 6876-6884.
Chen, A.Y. et al., (2005) Silatecan DB-67 is a novel DNA topoisomerase I-targeted radiation sensitizer. Mol. Cancer Thera. 4, 317-324.
Das, C. et al., (2006) Transcripional coactivator PC4, a chromatin-associated protein, induces chromatin condensation. Mol. Cell. Biol. 26 8303-8315.
Kleivi, K. et al., (2007) Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol. Cancer 6, 1-16.
Domain antibodies (dAbs) (for review, see Holt et al., 2003, Trends in Biotechnology 21:484-490) are also suitable for the methods of the present invention.
Harlow and Lane, 1988, Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Morrison et al., 1984, Proc. Natl. Acad. Sci. USA, 81:6851-6855.
Neuberger et al., 1984, Nature, 312:604-608.
Takeda et al., 1985, Nature, 314:452-454.
Huston et al., 1988, Proc. Natl. Acad. Sci. USA, 85:5879-5883.
Bird, 1988, Science, 242:423-426.
Ward et al., 1989, Nature, 334:544-546.
Wolff et al., 1984, Biochem. et Biophys. Acta, 802:259.
Hunter et al., 1975, J. Biol. Chem. 250: 409-17.
Manche et al., 1992, Mol. Cell. Biol. 12:5239-48.
Minks et al., 1979, J. Biol. Chem. 254:10180-3.
Elbashir et al., 2001, Nature 411: 494-8.
Bass, 2001, Nature 411:428-9.
Elbashir et al., 2001, Genes Dev. 15:188-200.
Jaeger et al., 1989, Proc. Natl. Acad. Sci. USA 86:7706.
Turner et al.., 1988, Annu. Rev. Biophys. Biophys. Chem. 17:167.
Kehlenback et al., 1998, J. Cell Biol. 141:863-74.
Ge, H. (2000) UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. Nucleic Acids Res. 28, e3.
PCT/CN08/072274 EPO Search Report of Nov. 23, 2010.
PCT/CN08/072274 PCT Patentability Report of Dec. 11, 2008.
PCT/CN08/072274 PCT Search Report of Dec. 11, 2008.
Wang et al., Mol. Cell. vol. 1(5):1097-2765 Apr. 5, 1998.
Bielawski et al., Pharmaceutical Society of Japan vol. 29(7): 1493-1497 Jul. 1, 2006.
Meng et al., Current Topics in Medicinal Chemistry, Bentham Science Publishers, Netherlands, vol. 3(3): 305-320 Jan. 1, 2003.
Codegoni et al., Annals of Oncology vol. 9(3): 313-319 Mar. 3, 1998.
Ginger et al., Nature vol. 330(6149): 670-672 Date: 1987.
Van Hoy et al., Cell vol. 72(4): 587-594 Feb. 23, 1993.
Ansari et al., PNAS vol. 102(7): 2346-2349 Feb. 15, 2005.

Affiliated with

Also associated with

Rating

Method and composition for cancer diagnosis and treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and composition for cancer diagnosis and treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for cancer diagnosis and treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4272354